PHIO Phio Pharmaceuticals Corp. - Common Stock
$1,05
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$1–$4
6% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
$14
+1233% upside
P/E (TTM)
-0.2
ROE
-57.5%
Margen de Beneficio Neto
—
PHIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.05
Capitalización Bursátil
$12M
P/E (TTM)
-0.2
BPA (TTM)
$-9.08
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-57.5%
Deuda/Capital
—
Rango 52S
$1 – $4
PHIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
2016-12-31
→
2020-12-31
BPA
$-9.08
2021-12-31
→
2024-12-31
Flujo de caja libre
$-8M
2016-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
PHIO
Mediana de Pares
P/E (TTM)
-0.2
—
P/B (P/C)
0.6
1.8
Price / FCF (Precio / FCF)
-1.5
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
PHIO
Mediana de Pares
ROA
-63.9%
-102.4%
ROE
-57.5%
-82.4%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
PHIO
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
PHIO
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
PHIO
Mediana de Pares
PHIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
1 analistas · 2026-08-19
Mín
$14.00
Máx
$14.00
Objetivo mediano
$14.00
+1233,2%
Objetivo medio
$14.00
+1233,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.06%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.36 | $-0.37 | 0.01% |
| 31 de marzo de 2026 | $-0.34 | $-0.24 | -0.10% |
| 31 de diciembre de 2025 | $-0.25 | $-0.35 | 0.09% |
| 30 de septiembre de 2025 | $-0.44 | $-0.46 | 0.02% |
| 30 de junio de 2025 | $-0.45 | $-0.37 | -0.08% |
| 31 de diciembre de 2024 | $-0.85 | $-1.25 | 0.40% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| AIXC | — | -0.3 | — | — | — | — |
| SNTI | — | -0.4 | -40.2% | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| PDSB | — | -1.0 | — | — | — | — |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| BIVI | — | — | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | · | |
| R&D Expense | $5M | $4M | $6M | $7M | $9M | $4M | $4M | $4M | $5M | $5M | $7M | $6M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $9M | $7M | $11M | $11M | $14M | $9M | $9M | $8M | $14M | $9M | $10M | $9M | |
| Operating Income | $-9M | $-7M | $-11M | $-11M | $-14M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Other Non-op | $2.0K | $6.0K | $-2.0K | $-18.0K | $224.0K | $-1.0K | $79.0K | $4.0K | $-11.0K | $6.0K | $-2.0K | $9.0K | |
| Pretax Income | · | · | · | $-11M | $-13M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2M | $0 | $0 | $0 | |
| Net Income | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| EPS (Basic) | $-1.45 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| Shares (Basic) | 5,984,017 | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| EBITDA | $-9M | $-7M | $-11M | $-11M | · | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M |
Balance general 20
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $5M | $8M | $12M | $24M | $14M | $7M | $15M | $4M | $13M | $5M | $8M | |
| Prepaid Expense | $445.0K | $354.0K | $832.0K | $615.0K | $620.0K | $870.0K | $316.0K | $221.0K | $201.0K | $150.0K | $311.0K | $442.0K | |
| Current Assets | $21M | $6M | $9M | $12M | $25M | $15M | $7M | $15M | $4M | $13M | $11M | $9M | |
| PP&E (Net) | $11.0K | $2.0K | $6.0K | $183.0K | $133.0K | $157.0K | $210.0K | $172.0K | $248.0K | $114.0K | $163.0K | $183.0K | |
| PP&E (Gross) | $239.0K | $308.0K | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Accum. Depreciation | $228.0K | $306.0K | $1M | $1M | $1M | $1M | $1M | $981.0K | $900.0K | $831.0K | $778.0K | $702.0K | |
| Other Non-current Assets | · | $0 | $3.0K | $24.0K | $27.0K | $18.0K | $18.0K | $0 | $18.0K | $27.0K | $18.0K | $18.0K | |
| Total Assets | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Accounts Payable | $435.0K | $253.0K | $657.0K | $779.0K | $283.0K | $728.0K | $809.0K | $550.0K | $511.0K | $917.0K | $1M | $285.0K | |
| Accrued Liabilities | $905.0K | $762.0K | $942.0K | $1M | $3M | $1M | $964.0K | $1M | $2M | $2M | $1M | $1M | |
| Current Liabilities | · | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Capital Leases | · | $0 | $0 | $35.0K | $170.0K | $295.0K | $411.0K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $1M | $2M | $2M | $3M | $3M | $2M | $2M | · | · | · | · | |
| Total Debt | · | · | · | · | · | $231.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $0 | $0 | $0 | $1.0K | $2.0K | |
| Paid-in Capital | $175M | $151M | $147M | $139M | $139M | $117M | $101M | $99M | $80M | $73M | $66M | $48M | |
| Retained Earnings | $-155M | $-146M | $-139M | $-128M | $-117M | $-104M | $-95M | $-86M | $-79M | $-66M | $-57M | $-47M | |
| Stockholders' Equity | $20M | $5M | $8M | $11M | $22M | $13M | $6M | $14M | $2M | $11M | $9M | $3M | |
| Liabilities + Equity | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Shares Outstanding | 11,617,250 | 1,733,717 | 416,368 | 1,139,024 | 1,127,917 | 5,780,973 | 669,433 | 342,578 | 2,429,993 | 1,300,318 | 653,485 | 21,984,272 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $2.0K | $56.0K | $71.0K | $75.0K | $72.0K | $67.0K | $81.0K | $70.0K | $53.0K | $77.0K | $87.0K | |
| Stock-based Comp | $481.0K | $147.0K | $303.0K | $414.0K | $480.0K | $136.0K | $300.0K | $282.0K | $314.0K | $756.0K | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $-2M | $-4M | $-4M | $-3M | |
| Other Non-cash | $235.0K | $-111.0K | $-282.0K | $-1M | · | $-216.0K | $-104.0K | $-523.0K | $4M | $4M | $5M | $2M | |
| Operating Cash Flow | $-8M | $-7M | $-11M | $-12M | $-12M | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M | |
| CapEx | $12.0K | $1.0K | $5.0K | $121.0K | $51.0K | $19.0K | $72.0K | $5.0K | $203.0K | $4.0K | $57.0K | $95.0K | |
| Investing Cash Flow | $-12.0K | $8.0K | $-5.0K | $-121.0K | $-51.0K | $-19.0K | $-72.0K | $-5.0K | $-103.0K | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $1M | $290.0K | · | $9M | $2M | |
| Net Stock Activity | · | · | · | · | · | · | · | $1M | · | · | $9M | $2M | |
| Financing Cash Flow | $24M | $4M | $7M | $-26.0K | $22M | $16M | $772.0K | $19M | $292.0K | · | · | · | |
| Net Change in Cash | $16M | $-3M | · | · | · | · | · | $11M | $-9M | $8M | $-3M | $-3M | |
| Free Cash Flow | $-8M | $-7M | $-11M | $-12M | · | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -3197.8% | · | · | · | · | -42795.2% | -5336.2% | -93746.7% | -47447.4% | · | · | |
| Net Margin | · | -3095.2% | · | · | · | · | -42419.0% | -5333.3% | -83013.3% | -47336.8% | · | · | |
| Pretax Margin | · | · | · | · | · | · | -42419.0% | -5333.3% | -93820.0% | -47336.8% | · | · | |
| EBITDA Margin | · | -3197.0% | · | · | · | · | -42476.2% | -5277.5% | -93280.0% | -47168.4% | · | · | |
| ROA | -63.9% | -94.7% | -97.6% | -60.5% | · | -74.0% | -76.3% | -75.8% | -142.3% | -73.2% | -100.5% | -73.0% | |
| ROE | -57.5% | -147.9% | -144.9% | -94.2% | · | -61.8% | -133.4% | -96.0% | -196.3% | -91.1% | -175.7% | -229.0% | |
| ROIC | · | · | · | -105.8% | · | -66.4% | -156.3% | -54.2% | -678.8% | -83.0% | -115.1% | -321.5% |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.7 | 5.7 | 6.4 | · | 6.9 | 3.9 | 8.7 | 1.7 | 5.2 | 4.8 | 6.7 | |
| Quick Ratio | · | 5.3 | 5.2 | 6.1 | · | 6.5 | 3.7 | 8.5 | 1.6 | 5.1 | 2.3 | 6.4 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Valoración (TTM) 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | $399.0K | |
| Net Income TTM | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| Market Cap | $12M | $3M | $26M | $46M | · | $1.68B | $680M | $36.93B | $42.94B | $552.26B | $14.83T | $11.20T | |
| Enterprise Value | · | · | · | · | · | $1.67B | · | · | · | · | · | · | |
| P/E | -0.2 | -0.2 | -0.1 | -4.0 | -8.7 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 32379.5 | 267635.7 | 2862988.0 | 29066211.3 | 436124657.3 | 28078591.4 | |
| P/B | 0.6 | 0.7 | 3.3 | 4.2 | · | 129.0 | 118.3 | 2720.1 | 23428.7 | 50875.9 | 1667968.3 | 4081369.0 | |
| P / Tangible Book | 0.6 | 0.7 | 3.3 | 4.2 | 66.7 | 129.0 | · | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -0.4 | -2.4 | -3.8 | · | -190.8 | -78.7 | -4911.4 | -4513.9 | -71167.3 | -2026546.2 | -1444103.9 | |
| P / FCF | -1.5 | -0.4 | -2.4 | -3.7 | · | -190.4 | -78.0 | -4908.1 | -4419.6 | -71130.6 | -2010881.3 | -1426634.1 | |
| EV / EBITDA | · | · | · | · | · | -191.0 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -188.8 | · | · | · | · | · | · | |
| Earnings Yield | -573.3% | -504.4% | -683.6% | -25.1% | -11.5% | · | · | · | · | · | · | · |
Estado de resultados 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $1M | $1M | $1M | $886.0K | $985.0K | $644.0K | $866.0K | $1M | $1M | $2M | $1M | $2M | $2M | $3M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $986.0K | $689.0K | $946.0K | $1M | $1M | $766.0K | $968.0K | $1M | $1M | $1M | $1M | |
| Operating Expenses | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | |
| Operating Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $0 | $3.0K | $-119.0K | $0 | $0 | $-22.0K | $-64.0K | $0 | $68.0K | $2.0K | · | $-4.0K | $-2.0K | $0 | $-1.0K | $-5.0K | |
| Net Income | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| EPS (Basic) | $-0.36 | $-0.34 | $-0.15 | $-0.44 | $-0.45 | $-0.41 | $-3.45 | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| EPS (Diluted) | · | · | · | · | $-0.45 | $-0.41 | · | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| Shares (Basic) | 11,617,250 | 11,617,250 | -8,586,688 | 5,468,584 | 4,794,857 | 4,307,264 | -5,292,827 | 990,033 | 510,188 | 4,580,072 | -1,373,888 | 271,129 | 192,054 | 1,142,213 | -1,139,359,349 | 1,138,571 | |
| Shares (Diluted) | · | · | · | · | 4,794,857 | 4,307,264 | · | 990,033 | 510,188 | 4,580,072 | -1,373,888 | 271,129 | 192,054 | 1,142,213 | -1,139,359,349 | 1,138,571 | |
| EBITDA | $-4M | $-4M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-4M | · | $-4M |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $21M | $11M | $11M | $13M | $5M | $5M | $5M | $6M | $8M | $8M | $11M | $9M | $12M | $14M | |
| Prepaid Expense | $1M | $371.0K | $445.0K | $788.0K | $519.0K | $158.0K | $354.0K | $474.0K | $594.0K | $373.0K | $832.0K | $871.0K | $678.0K | $319.0K | $615.0K | $843.0K | |
| Current Assets | $14M | $17M | $21M | $11M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $9M | $12M | $9M | $12M | $15M | |
| PP&E (Net) | $9.0K | $10.0K | $11.0K | $12.0K | $7.0K | $4.0K | $2.0K | $1.0K | $1.0K | $2.0K | $6.0K | $142.0K | $157.0K | $167.0K | $183.0K | $198.0K | |
| PP&E (Gross) | · | · | $239.0K | · | · | · | $308.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $228.0K | · | · | · | $306.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | $3.0K | $3.0K | $6.0K | $6.0K | $24.0K | $24.0K | |
| Total Assets | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Accounts Payable | $901.0K | $260.0K | $435.0K | $516.0K | $235.0K | $427.0K | $253.0K | $184.0K | $335.0K | $320.0K | $657.0K | $173.0K | $641.0K | $902.0K | $779.0K | $543.0K | |
| Accrued Liabilities | $804.0K | $690.0K | $905.0K | $1M | $971.0K | $843.0K | $762.0K | $735.0K | $1M | $929.0K | $942.0K | $2M | $2M | $1M | $1M | $2M | |
| Current Liabilities | · | · | · | · | $1M | $1M | · | $919.0K | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $35.0K | $70.0K | |
| Total Liabilities | $2M | $950.0K | $1M | $2M | $1M | $1M | $1M | · | · | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | |
| Paid-in Capital | $176M | $176M | $175M | $163M | $160M | $160M | $151M | $150M | $147M | $147M | $147M | $145M | $144M | $139M | $139M | $139M | |
| Retained Earnings | $-163M | $-159M | $-155M | $-153M | $-150M | $-148M | $-146M | $-145M | $-143M | $-141M | $-139M | $-137M | $-135M | $-132M | $-128M | $-126M | |
| Stockholders' Equity | $13M | $16M | $20M | $10M | $10M | $12M | $5M | $5M | $4M | $6M | $8M | $7M | $10M | $7M | $11M | $14M | |
| Liabilities + Equity | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Shares Outstanding | 11,617,250 | 11,617,250 | 11,617,250 | 5,784,770 | 4,798,154 | 4,778,154 | 1,733,717 | 958,219 | 510,188 | 4,591,700 | 416,368 | 2,307,385 | 1,985,211 | 1,150,582 | 1,139,024 | 13,667,973 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $10.0K | $15.0K | $15.0K | $16.0K | $15.0K | $15.0K | |
| Stock-based Comp | $278.0K | $318.0K | $274.0K | $113.0K | $51.0K | $43.0K | $48.0K | $52.0K | $15.0K | $32.0K | $9.0K | $89.0K | $94.0K | $111.0K | $42.0K | $103.0K | |
| Other Non-cash | · | $-319.0K | · | · | · | $451.0K | · | · | · | $110.0K | · | · | · | $767.0K | · | · | |
| Operating Cash Flow | $-4M | $-4M | $-2M | $-2M | $-3M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-4M | |
| CapEx | $0 | $0 | $0 | $7.0K | $3.0K | $2.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $5.0K | $0 | $0 | $7.0K | |
| Investing Cash Flow | $0 | $3.0K | $0 | $-7.0K | $-3.0K | $-2.0K | $8.0K | $0 | $0 | $0 | $0 | $0 | $-5.0K | $0 | $0 | $-7.0K | |
| Financing Cash Flow | $0 | $0 | $12M | $2M | $40.0K | $9M | $1M | $3M | $0 | $-4.0K | $2M | $0 | $5M | $-38.0K | $2.0K | $-3.0K | |
| Net Change in Cash | $-4M | $-4M | $10M | $-70.0K | $-3M | $8M | $-8.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-1M | · | · | · | · | · | · | · | $-3M | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -32.3% | -25.9% | · | -27.5% | -26.1% | -17.4% | · | -19.8% | -21.0% | -26.0% | · | -21.9% | -15.7% | -22.6% | · | -16.4% | |
| ROE | -36.5% | -28.0% | · | -32.4% | -31.2% | -19.9% | · | -25.1% | -27.0% | -33.4% | · | -26.8% | -18.9% | -26.9% | · | -18.4% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 9.4 | 10.6 | · | 6.4 | 3.5 | 5.5 | · | 4.0 | 5.0 | 3.9 | · | 7.0 | |
| Quick Ratio | · | · | · | · | 8.9 | 10.5 | · | 5.9 | 3.1 | 5.2 | · | 3.6 | 4.7 | 3.8 | · | 6.6 |
Valoración (TTM) 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-13M | $-10M | · | $-8M | $-7M | $-7M | · | $-8M | $-9M | $-11M | · | $-13M | $-12M | $-12M | · | $-12M | |
| Market Cap | $12M | $14M | · | $14M | $11M | $6M | · | $3M | $3M | $28M | · | $31M | $51M | $58M | · | $843M | |
| P/E | -0.2 | -0.2 | · | -0.4 | -0.4 | -0.2 | · | -0.2 | -0.2 | -0.2 | · | -0.5 | -1.2 | -4.7 | · | -7.7 | |
| P/B | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Tangible Book | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Cash Flow | · | -3.5 | · | · | · | -4.9 | · | · | · | -14.0 | · | · | · | -21.5 | · | · | |
| P / FCF | · | -3.5 | · | · | · | -4.9 | · | · | · | · | · | · | · | -21.5 | · | · | |
| Earnings Yield | -587.3% | -493.4% | · | -242.7% | -256.2% | -464.6% | · | -460.3% | -443.3% | -443.5% | · | -219.3% | -84.3% | -21.4% | · | -12.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | — | -3197.8% | — | — | — |
| Beneficio neto | $-9M | $-7M | $-11M | $-11M | $-13M |
| EPS Diluido | — | $-9.08 | $-46.76 | $-10.10 | $-12.43 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | — | 5.7 | 5.7 | 6.4 | — |
| Ratio Rápido | — | 5.3 | 5.2 | 6.1 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-8M | $-7M | $-11M | $-12M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 25 declarantes · $661K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 6 (-7 vs trimestre anterior) | 4 (-1 vs trimestre anterior) | 5 (0 vs trimestre anterior) | 8 (+8 vs trimestre anterior) | +101K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $108 679 | 106 028 | 16,44% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $96 619 | 94 262 | 14,62% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $91 656 | 89 421 | 13,87% | Acciones |
| VANGUARD GROUP INC | $51 932 | 49 459 | 7,86% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $51 000 | 50 000 | 7,72% | Acciones |
| Cetera Investment Advisers | $48 688 | 47 500 | 7,37% | Acciones |
| CITADEL ADVISORS LLC | $48 329 | 47 150 | 7,31% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $39 123 | 38 169 | 5,92% | Acciones |
| NORTHERN TRUST CORP | $25 677 | 25 051 | 3,89% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $22 039 | 21 501 | 3,33% | Acciones |
| XTX Topco Ltd | $18 937 | 18 475 | 2,87% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $12 300 | 12 000 | 1,86% | Acciones |
| CITIGROUP INC | $11 895 | 11 605 | 1,80% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $10 250 | 10 000 | 1,55% | Acciones |
| Tower Research Capital LLC (TRC) | $6 361 | 6 206 | 0,96% | Acciones |
| MORGAN STANLEY | $6 150 | 6 000 | 0,93% | Acciones |
| UBS Group AG | $5 522 | 5 387 | 0,84% | Acciones |
| OSAIC HOLDINGS, INC. | $2 060 | 2 000 | 0,31% | Acciones |
| Spire Wealth Management | $2 050 | 1 990 | 0,31% | Acciones |
| SBI Securities Co., Ltd. | $1 278 | 1 247 | 0,19% | Acciones |
| BARCLAYS PLC | $237 | 231 | 0,04% | Acciones |
| ASSETMARK, INC | $113 | 110 | 0,02% | Acciones |
| HRT FINANCIAL LP | $13 | 13 182 | 0,00% | Acciones |
| Activest Wealth Management | $9 | 9 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $6 | 6 | 0,00% | Acciones |
Informantes de la empresa 14 insiders · 6 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Robert J Bitterman | Chairman, Pres. & CEO | 26 de junio de 2026 P | 421 421 | 1 | 0 | $9 900 |
| Gerrit Dispersyn | President & CEO | 1 de marzo de 2022 F | 212 327 | 0 | 0 | $0 |
| Caitlin Kontulis | Secretary & VP Finance & Admin | 1 de marzo de 2023 F | 12 159 | 0 | 0 | $0 |
| John A Barrett | Chief Development Officer | 22 de abril de 2019 A | 222 991 | 0 | 0 | $0 |
| Alexey Eliseev | Chief Business Officer | 7 de septiembre de 2017 S | 950 312 | 0 | 0 | $0 |
| Pamela Pavco | Chief Development Officer | 1 de febrero de 2017 A | 17 173 | 0 | 0 | $0 |
| Robert L Ferrara | Consejero | 10 de junio de 2025 P | 15 666 | 0 | 0 | $0 |
| Jonathan E Freeman | Consejero | 17 de febrero de 2023 A | 3 197 | 0 | 0 | $0 |
| Curtis Lockshin | Consejero | 17 de febrero de 2023 A | 3 197 | 0 | 0 | $0 |
| Patricia A Bradford | Consejero | 17 de febrero de 2023 A | 3 167 | 0 | 0 | $0 |
| Geert Cauwenbergh | Consejero | 17 de febrero de 2023 A | 4 235 | 0 | 0 | $0 |
| Paul H. Dorman | Consejero | 15 de febrero de 2022 A | 20 370 | 0 | 0 | $0 |
| Keith L Brownlie | Consejero | 13 de febrero de 2019 A | 20 000 | 0 | 0 | $0 |
| Galena Biopharma, Inc. | — | 2 de mayo de 2013 S | 32 393 095 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 94 262 SH | 8 de agosto de 2026 | Diario |